Cargando…
Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation
The development of new bioactive compounds represents one of the main purposes of the drug discovery process. Various tools can be employed to identify new drug candidates against pharmacologically relevant biological targets, and the search for new approaches and methodologies often represents a cr...
Autores principales: | Gazzillo, Erica, Terracciano, Stefania, Ruggiero, Dafne, Potenza, Marianna, Chini, Maria Giovanna, Lauro, Gianluigi, Fischer, Katrin, Hofstetter, Robert Klaus, Giordano, Assunta, Werz, Oliver, Bruno, Ines, Bifulco, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228872/ https://www.ncbi.nlm.nih.gov/pubmed/35744994 http://dx.doi.org/10.3390/molecules27123866 |
Ejemplares similares
-
Benzoxazolone-5-Urea
Derivatives as Human Soluble
Epoxide Hydrolase (sEH) Inhibitors
por: Gur Maz, Tugce, et al.
Publicado: (2023) -
Development of an online SPE–LC–MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors
por: Schebb, Nils Helge, et al.
Publicado: (2011) -
Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases
por: Arand, Michael, et al.
Publicado: (2017) -
Reply to “Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases”
por: Goldberg, Daniel E., et al.
Publicado: (2017) -
Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases
por: Hanif, Ahmad, et al.
Publicado: (2017)